![Klaus Christian Schollmeier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Klaus Christian Schollmeier
Presidente presso Embark Laboratories ApS
Profilo
Klaus Christian Schollmeier is currently the Chairman at Embark Laboratories ApS.
He was previously the Chairman at Novo Nordisk Research Center Gladsaxe ApS.
Posizioni attive di Klaus Christian Schollmeier
Società | Posizione | Inizio |
---|---|---|
Embark Laboratories ApS
![]() Embark Laboratories ApS BiotechnologyHealth Technology Embark Laboratories ApS is a Danish biotech company that focuses on cardiometabolic disease. The private company is based in Copenhagen, Denmark. The company was founded in 2023. Casper Tind Hansen has been the CEO of the company since 2023. | Presidente | 05/07/2023 |
Precedenti posizioni note di Klaus Christian Schollmeier
Società | Posizione | Fine |
---|---|---|
Embark Biotech ApS
![]() Embark Biotech ApS Miscellaneous Commercial ServicesCommercial Services Novo Nordisk Research Center Gladsaxe ApS is based in Bagsværd, Denmark. The Danish company is a spin-out from the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen. The company discovered a novel target that suppresses appetite, increases energy expenditure, and enhances insulin sensitivity. The development of the target was initiated through a collaboration with Novo Nordisk and further matured with support from the Innobooster program at the Innovation Fund Denmark and the Bioinnovation Institute (BII) during a residency in the Venture House program. Part of Novo Nordisk A/S, Novo Nordisk Research Center Gladsaxe ApS is a biotech company that was founded in 2017. The CEO of the company is Casper Tind Hansen. Novo Nordisk Research Center Gladsaxe was acquired by Novo Nordisk A/S from Embark Laboratories ApS on August 28, 2023 for $68.06 million. | Presidente | 29/08/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Embark Biotech ApS
![]() Embark Biotech ApS Miscellaneous Commercial ServicesCommercial Services Novo Nordisk Research Center Gladsaxe ApS is based in Bagsværd, Denmark. The Danish company is a spin-out from the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen. The company discovered a novel target that suppresses appetite, increases energy expenditure, and enhances insulin sensitivity. The development of the target was initiated through a collaboration with Novo Nordisk and further matured with support from the Innobooster program at the Innovation Fund Denmark and the Bioinnovation Institute (BII) during a residency in the Venture House program. Part of Novo Nordisk A/S, Novo Nordisk Research Center Gladsaxe ApS is a biotech company that was founded in 2017. The CEO of the company is Casper Tind Hansen. Novo Nordisk Research Center Gladsaxe was acquired by Novo Nordisk A/S from Embark Laboratories ApS on August 28, 2023 for $68.06 million. | Commercial Services |
Embark Laboratories ApS
![]() Embark Laboratories ApS BiotechnologyHealth Technology Embark Laboratories ApS is a Danish biotech company that focuses on cardiometabolic disease. The private company is based in Copenhagen, Denmark. The company was founded in 2023. Casper Tind Hansen has been the CEO of the company since 2023. | Health Technology |
- Borsa valori
- Insiders
- Klaus Christian Schollmeier